HR 328 109th Congress House Health Administrative fees Administrative procedure Administrative remedies Business records Civil actions and liability Commerce Congress Congressional reporting requirements Consumer education Consumer protection Damages Department of Health and Human Services Drug approvals Drug industry Drugs Economics and Public Finance Electronic government information Evidence (Law) Federal Trade Commission

Pharmaceutical Market Access Act of 2005

Introduced: May 17, 2005 See on congress.gov

Everywhere this bill has been 11 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 21, 2005

Sponsor introductory remarks on measure. (CR H4861)

Jun 20, 2005

Sponsor introductory remarks on measure. (CR H4784-4785)

May 17, 2005

Sponsor introductory remarks on measure. (CR H3406-3407)

May 16, 2005

Sponsor introductory remarks on measure. (CR H3289-3290)

Apr 13, 2005

Sponsor introductory remarks on measure. (CR H1945-1946)

Apr 5, 2005

Sponsor introductory remarks on measure. (CR H1754)

Mar 2, 2005

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Feb 25, 2005

Referred to the Subcommittee on Health.

Feb 15, 2005

Sponsor introductory remarks on measure. (CR H606)

Jan 25, 2005

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 25, 2005

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, wholesalers, and individuals to import qualifying drugs from certain countries into the United States.

Sets forth registration requirements for exporters.

Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters.

Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies.

Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order.

Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement.

Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug.

Allows the Secretary to suspend or terminate the registration of an exporter for failing to maintain substantial compliance with all registration conditions.

What's happening now June 21, 2005

Sponsor introductory remarks on measure. (CR H4861)

Related & companion bills 2

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 4

Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
House of Representatives · subcommittee of Judiciary Committee
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Judiciary Committee
House of Representatives

Cosponsors 24

Larsen, Rick

Washington · Jul 14, 2005

Costa, Jim

California · Jul 11, 2005

Davis, Danny K.

Illinois · Jul 11, 2005

Wasserman Schultz, Debbie

Florida · May 24, 2005

Pelosi, Nancy

California · May 17, 2005

Schiff, Adam B.

California · May 17, 2005

Sánchez, Linda T.

California · May 10, 2005

Cuellar, Henry

Texas · Apr 28, 2005

Bishop, Sanford D.

Georgia · Apr 21, 2005

Schakowsky, Janice D.

Illinois · Mar 8, 2005

Cleaver, Emanuel

Missouri · Feb 17, 2005

Larson, John B.

Connecticut · Feb 17, 2005

McCollum, Betty

Minnesota · Feb 9, 2005

Boozman, John

Arkansas · Feb 8, 2005

Nadler, Jerrold

New York · Feb 8, 2005

Case, Ed

Hawaii · Feb 1, 2005

McGovern, James P.

Massachusetts · Feb 1, 2005

Pallone, Frank

New Jersey · Feb 1, 2005

Simpson, Michael K.

Idaho · Feb 1, 2005

Van Hollen, Chris

Maryland · Feb 1, 2005

DeLauro, Rosa L.

Connecticut · Jan 25, 2005

Sanders, Bernard

Vermont · Jan 25, 2005

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 328: Pharmaceutical Market Access Act of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-328/

MLA

"H.R. 328: Pharmaceutical Market Access Act of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-328/.

Bluebook (legal)

H.R. 328, 109th Cong. (2026), https://openamerica.io/bill/109-HR-328/.

Markdown link

[H.R. 328: Pharmaceutical Market Access Act of 2005](https://openamerica.io/bill/109-HR-328/)